Results for tag: "Myocardial Protection"

The Myocardial Protection market is a subset of the larger Surgical Procedures market. It focuses on the protection of the heart during surgery, typically through the use of drugs or devices. These drugs and devices are used to reduce the risk of ischemia, or lack of oxygen, to the heart muscle during surgery. This is done by reducing the amount of blood flow to the heart, or by increasing the amount of oxygen in the blood. The goal is to reduce the risk of complications and improve the outcome of the surgery. Myocardial protection is an important part of many surgical procedures, including coronary artery bypass grafting, valve replacement, and aortic aneurysm repair. It is also used in other types of surgeries, such as those involving the heart, lungs, and kidneys. Companies in the Myocardial Protection market include Medtronic, Abbott, Edwards Lifesciences, and St. Jude Medical. These companies provide a variety of products, including drugs, devices, and other technologies, to help protect the heart during surgery. Show Less Read more